Abstract: Compounds based on alkyl polyglycosides for use in the treatment of Streptococcus agalactiae infections and other pathogens are provided. Such compounds may belong to the class of alkyl glucosides or alkyl polyglucosides. Additional active ingredients may be used which may include middle-chain saturated fatty acids or the glycerol ester derivatives thereof. Representative middle-chain saturated fatty acids or the glycerol ester derivatives thereof include: lauric acid, capric acid, caprylic acid and caproic acid and the glycerol ester derivatives thereof. Formulations which include these compounds and methods of using such compositions and formulations in the treatment and/or prevention of bacterial infections of the vaginal tract are also provided.

Abstract: Novel pharmaceutical compositions contain micronized progesterone and at least one oleic safflower oil referred to as safflower oil type II, and medicines comprising said compositions are useful in treating progesterone insufficiency in women.

Abstract: The invention concerns compounds capable of being fixed on hormone receptors and having a nitrogen monoxide donor group and their use for preventing premature births, increasing cervical dilatation, for use in hormone substitution therapy as anti-hypertensive drug and their therapeutic use for preparing a medicine for use in obstetrics and gynecology.

Abstract: A pharmaceutical composition, intended for menopausal replacement therapy, comprising a suspension of progesterone in a lipophilic medium solution of a 17-estradiol salt in the lipophilic medium, the weight ratio of progesterone to the base 17-estradiol being 25 to 600.

Abstract: A process for the production of a solid dispersion of at least one therapeutic agent in a hydrophilic carrier having enhanced solubility in an aqueous media comprising dissolving at least one therapeutic agent in a volatile organic solvent containing a very hydrophilic polymer and evaporating the solvent to dryness to form a co-precipitate of therapeutic agent and hydrophilic polymer and the resulting products and their therapeutic method of use.

Abstract: A process for the production of a solid dispersion of at least one therapeutic agent in a hydrophilic carrier having enhanced solubility in an aqueous media comprising dissolving at least one therapeutic agent in a volatile organic solvent containing a very hydrophilic polymer and evaporating the solvent to dryness to form a co-precipitate of therapeutic agent and hydrophilic polymer and the resulting products and their therapeutic method of use.